Disclosure under Regulation 30 of SEBI Listing Regulations - Intimation regarding completion of US FDA inspection Unit 2

By Anonymous (not verified), 3 August, 2026

Disclosures to Stock Exchange

2025-26

NA

PDF

IntimationregardingcompletionofUSFDAinspectionUnit2.pdf (277.23 KB)